The ESMO Sarcoma and Rare Cancers Congress 2026 will take place from 12–14 March in Lugano, Switzerland, offering a premier platform for experts to share cutting-edge research and innovative treatment approaches in rare solid tumours.
The congress will discuss the latest developments in diagnosis, treatment, molecular biology, and classification of sarcomas and other rare cancers. The programme includes a wide range of sessions such as abstract presentations, educational lectures, multidisciplinary tumour boards, guidelines updates, and dedicated discussions for young oncologists. With opportunities for clinicians, researchers, industry professionals, and patient advocates to connect and collaborate, the congress promises three days of enriching scientific exchange and community building in the field of rare cancers.
